Orange Book product · Generic (ANDA)
NEO-FRADIN
NEOMYCIN SULFATE
At a glance
May 23, 2002
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 23, 2002
24 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
NEOMYCIN SULFATE
Strength
EQ 87.5MG BASE/5ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 065010
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NEOMYCIN SULFATE
- —MYCIFRADINBrand (NDA)
NDA 050285 · PHARMACIA AND UPJOHN
- 2016NEOMYCIN SULFATEGeneric (ANDA)
ANDA 204435 · CHARTWELL MOLECULAR
- 2010NEOMYCIN SULFATEGeneric (ANDA)
ANDA 065468 · PHARMOBEDIENT
- 2006NEOMYCIN SULFATEGeneric (ANDA)
ANDA 065220 · SOLARIS PHARMA CORP
- —MYCIFRADINGeneric (ANDA)
ANDA 060520 · PHARMACIA AND UPJOHN
- —NEOBIOTICGeneric (ANDA)
ANDA 060475 · PFIZER
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 060365 · BRISTOL MYERS SQUIBB
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 060607 · LANNETT
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 060385 · LILLY
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 062173 · ROXANE
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 061586 · SANDOZ
- —NEOMYCIN SULFATEGeneric (ANDA)
ANDA 060304 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
